Delivery Order SPE2DB20D2104-SPE2DB25FMKLP

Award Date 3/6/25
Potential Completion Date 3/7/25
Potential Value $3.4K
Ultimate Awardee
Not listed
Federal Contract Vehicle
Set-Aside Type
No Set-Aside Used
Extent Competed
Full and Open Competition
Major Defense Program
Not listed
Pricing Type
Firm Fixed Price
Place of Performance
Conshohocken, PA 19428, USA
Solicitation Procedures
Negotiated Proposal / Quote
Number Of Offers Received
Not listed
Legislative Mandate
Not listed
National Interest Action
Not listed
Research Type
Not listed
Primary Consortia Member
Not listed
Similar Awards
This is a delivery order contract awarded by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is for the supply of Timolol 0.25% Gel-Solution, a medical eye drop product, with a ceiling value of $9,324.26 and an ultimate completion date of February 7, 2024. The contract is a firm fixed-price agreement, with no set-aside designation. Amerisourcebergen holds a larger Indefinite Delivery Contract...
This federal contract award was issued by the Defense Logistics Agency (DLA) Troop Support Medical to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $2,309.28 firm fixed-price delivery order is for the supply of Timolol 0.5% Gel-Solution, a medication used for the treatment of eye conditions. The contract has a period of performance through January 31, 2023. AmerisourceBergen holds a $999,999,999 Indefinite Delivery Contract (IDC) with...
This is a federal contract awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract, with a ceiling value of $1,393.48, is for the delivery of Timolol Maleate 0.5% eye drops in 60-count units. This is a Firm Fixed Price Delivery Order contract with an ultimate completion date of November 15, 2024. The contract is not designated with a set-aside. AmerisourceBergen holds a significant Indefinite...
This is a delivery order contract awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is for the supply of Timolol 0.5% gel-solution, a medication used to treat glaucoma. The contract has a ceiling value of $8,265.49 and a period of performance through September 20, 2023. It is a firm-fixed-price contract, and there is no set-aside designation. AmerisourceBergen holds a $999,999,999...
This is a delivery order contract awarded by the Defense Logistics Agency (DLA) Troop Support Medical to Amerisourcebergen Drug Corp, a subsidiary of the parent company Cencora, Inc. The contract is for the delivery of Timolol 0.5% Gel-Solution, a medication used to treat certain eye conditions. The contract has a ceiling value of $22,933.67 and a period of performance through February 13, 2024. The contract was awarded on a firm fixed-price basis and was not set aside for any specific...
This federal contract award was issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $1,121.53 fixed-price delivery order is for the supply of 5mL bottles of Timolol 0.25% gel-solution, a medication used to treat glaucoma and other eye conditions. The contract has an ultimate completion date of November 25, 2024. AmerisourceBergen holds a significant $999,999,999 Indefinite Delivery Contract (IDC)...
This federal contract award, valued at $24,421.97, was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is for the delivery of Timolol 0.5% Gel-Solution, a prescription eye drop medication, and does not have a set-aside designation, indicating open competition. Amerisourcebergen holds a significant Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, valued at...
This is a delivery order contract awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor, for the supply of Timolol 0.5% gel-solution. The contract has a ceiling value of $8,822.64 and a period of performance through April 25, 2023. It is a firm-fixed-price contract, with no set-aside requirements. AmerisourceBergen holds a larger Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, valued at $999,999,999 and running...
The U.S. Defense Logistics Agency (DLA) Troop Support Medical awarded a delivery order contract to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $13,252.83 firm fixed-price contract is for the supply of Timolol 0.5% Gel-Solution, a prescription eye medication. This delivery order is part of a larger $999,999,999 Indefinite Delivery Contract (IDC) held by Amerisourcebergen with the DLA, which provides a wide range of pharmaceutical products...
This federal contract award, valued at $1,362.74, was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The award is a delivery order contract for the supply of Timolol 0.5% Gel-Solution, a prescription eye drop, to support military healthcare programs. The contract has an ultimate completion date of November 6, 2024 and is a firm fixed-price arrangement. It is not designated as a set-aside contract,...
  • SPE2DB20D2104
    Indefinite Delivery Contract
  • SPE2DB20D2104-SPE2DB25FMKLP
    Delivery Order

This is a delivery order awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is for the supply of Timolol 0.5% Gel-Solution, a prescription eye drop medication, with a ceiling value of $3,363.12 and a period of performance through March 7, 2025. The contract is a firm fixed price delivery order, with no set-aside designation indicated.

AmerisourceBergen holds a significant Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, valued at $999,999,999 and running through November 2026. This IDC serves as a primary vehicle for providing a comprehensive range of pharmaceutical products and medical supplies to support military healthcare programs globally. The company also maintains a separate IDC with the Department of Justice Federal Bureau of Investigation, valued at $750,000 through May 2024, which covers similar medical products and prescription drugs. These IDCs enable efficient government procurement of essential pharmaceutical and medical supplies, serving the healthcare needs of military personnel, veterans, and other federal beneficiaries.

Generated 6/5/25, 9:49 AM